miR-152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endometrial cancer

Cancer Research

Volumn 71, Issue 20, 2011, Pages 6450-6462

  Tsuruta, Tomohiko ^a,b   Kozaki, Ken Ichi ^a   Uesugi, Atsushi ^a   Furuta, Mayuko ^a   Hirasawa, Akira ^a,b   Imoto, Issei ^a   Susumu, Nobuyuki ^b   Aoki, Daisuke ^b   Inazawa, Johji ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLTRANSFERASE 1; MICRORNA; MICRORNA 152; TRANSCRIPTION FACTOR E2F3; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CHROMOSOME 17Q; CONTROLLED STUDY; COPZ2 GENE; CPG ISLAND; DNA METHYLATION; DNA SEQUENCE; DNMT1 GENE; E2F3 GENE; ENDOMETRIUM CANCER; EPIGENETICS; GENE IDENTIFICATION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTRON; MET GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RICTOR GENE; TUMOR GENE; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; CARRIER PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMOSOMES, HUMAN, PAIR 17; COATOMER PROTEIN; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; E2F3 TRANSCRIPTION FACTOR; ENDOMETRIAL NEOPLASMS; FEMALE; GENE SILENCING; GENES, TUMOR SUPPRESSOR; HUMANS; INTRONS; MICRORNAS; PROTO-ONCOGENE PROTEINS C-MET;

EID: 80054047147     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-11-0364     Document Type: Article

References (39)

1. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-97.
2. He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004;5:522-31. (Pubitemid 38868508)
3. Miska EA. How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev 2005;15:563-8. (Pubitemid 41262414)
4. Harfe BD. MicroRNAs in vertebrate development. Curr Opin Genet Dev 2005;15:410-5. (Pubitemid 40982092)
5. Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006;6:259-69.
6. Osada H, Takahashi T. MicroRNAs in biological processes and carcinogenesis. Carcinogenesis 2007;28:2-12. (Pubitemid 44942621)
7. Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003;349:2042-54. (Pubitemid 37448928)
8. Chuang JC, Jones PA. Epigenetics and microRNAs. Pediatr Res 2007;61:24R-29R. (Pubitemid 46653064)
9. Kozaki K, Imoto I, Mogi S, Omura K, Inazawa J. Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res 2008;68:2094-105. (Pubitemid 351521781)
10. Furuta M, Kozaki K, Tanaka S, Arii S, Imoto I, Inazawa J. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 2009;31:766-76.
11. Iorio MV, Piovan C, Croce CM. Interplay between microRNAs and the epigenetic machinery: an intricate network. Biochim Biophys Acta 2010;1799:694-701.
12. Dizon DS. Treatment options for advanced endometrial carcinoma. Gynecol 2010;117:373-81.
13. Murayama-Hosokawa S, Oda K, Nakagawa S, Ishikawa S, Yamamoto S, Shoji K, et al. Genome-wide single-nucleotide polymorphism arrays in endometrial carcinomas associate extensive chromosomal instability with poor prognosis and unveil frequent chromosomal imbalances involved in the PI3-kinase pathway. Oncogene 2010;29:1897-908.
14. Nakano H, Miyazawa T, Kinoshita K, Yamada Y, Yoshida T. Functional screening identifies a microRNA, miR-491 that induces apoptosis by targeting Bcl-X(L) in colorectal cancer cells. Int J Cancer 2010;127:1072-80.
15. Levy C, Khaled M, Iliopoulos D, Janas MM, Schubert S, Pinner S, et al. Intronic miR-211 assumes the tumor suppressive function of its host gene in melanoma. Mol Cell 2010;40:841-9.
16. Suzuki E, Imoto I, Pimkhaokham A, Nakagawa T, Kamata N, Kozaki K, et al. PRTFDC1, a possible tumor-suppressor gene, is frequently silenced in oral squamous-cell carcinomas by aberrant promoter hypermethylation. Oncogene 2007;26:7921-32. (Pubitemid 350261784)
17. miRBase database (Release 17 April 2011). Available from: http://www.mirbase.org/index.shtml.
18. UCSC Genome Browser on Human February 2009 Assembly (hg19). Available from: http://genome.ucsc.edu/cgi-bin/hgGateway.
19. PubMed. Available from: http://www.ncbi.nlm.nih.gov/pubmed.
20. miRanda. Available from: http://microrna.sanger.ac.uk/sequences/index. shtml.
21. TargetScan. Available from: http://www.targetscan.org/.
22. PicTar. Available from: http://pictar.mdc-berlin.de/.
23. Pierson J, Hostager B, Fan R, Vibhakar R. Regulation of cyclin dependent kinase 6 by microRNA 124 in medulloblastoma. J Neurooncol 2008;90:1-7.
24. Sun Y, Bai Y, Zhang F, Wang Y, Guo Y, Guo L. miR-126 inhibits non-small cell lung cancer cells proliferation by targeting EGFL7. Biochem Biophys Res Commu 2010;391:1483-9.
25. Braconi C, Huang N, Patel T. MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytes. Hepatology 2010;51:881-90.
26. Hresko RC, Mueckler M. mTOR.RICTOR is the Ser473 kinase for Akt/protein kinaseBin 3T3-L1 adipocytes. JBiolChem2005;280:40406-16. (Pubitemid 41780527)
27. Saito Y, Friedman JM, Chihara Y, Egger G, Chuang JC, Liang G. Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells. Biochem Biophys Res Commun 2009;379:726-31.
28. Svoboda P. Off-targeting and other non-specific effects of RNAi experiments in mammalian cells. Curr Opin Mol Ther 2007;9:248-57. (Pubitemid 46944316)
29. Stumpel DJ, Schotte D, Lange-Turenhout EA, Schneider P, Seslija L, de Menezes, et al. Hypermethylation of specific microRNA genes in MLL-rearranged infant acute lymphoblastic leukemia: major matters at a micro scale. Leukemia 2010;25:429-39.
30. Chen Y, Song Y, Wang Z, Yue Z, Xu H, Xing C, et al. Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical significance. J Gastrointest Surg 2010;14:1170-9.
31. Lee C, Goldberg J. Structure of coatomer cage proteins and the relationship among COPI, COPII, and clathrin vesicle coats. Cell 2010;142:123-32.
32. Razi M, Chan EY, Tooze SA. Early endosomes and endosomal coatomer are required for autophagy. J Cell Biol 2009;185:305-21.
33. Chen HZ, Tsai SY, Leone G. Emerging roles of E2Fs in cancer: an exit from cell cycle control. Nat Rev Cancer 2009;9:785-97.
34. Trusolino L, Bertotti A, Comoglio PM. MET signalling: principles and functions in development, organ regeneration and cancer. Nat Rev Mol Cell Biol 2010;11:834-48.
35. Roulin D, Cerantola Y, Dormond-Meuwly A, Demartines N, Dormond O. Targeting mTORC2 inhibits colon cancer cell proliferation in vitro and tumor formation in vivo. Mol Cell 2010;9:57.
36. Guertin DA, Stevens DM, Saitoh M, Kinkel S, Crosby K, Sheen JH, et al. mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice. Cancer Cell 2009;15:148-59.
37. Hietakangas V, Cohen SM. TOR complex 2 is needed for cell cycle progression and anchorage-independent growth of MCF7 and PC3 tumor cells. BMC Cancer 2008;8:282.
38. Kuo PL, Hsu YL, Cho CY. Plumbagin induces G2-M arrest and autophagy by inhibiting the AKT/mammalian target of rapamycin pathway in breast cancer cells. Mol Cancer Ther 2006;5:3209-21.
39. Liang J, Slingerland JM. Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell Cycle 2003;2:339-45.